GGenetics Read More Gene-Therapy Treatment Of Infant With Rare Genetic Condition Successful In World First » TwistedSifterAugust 18, 2025 Pexels When baby KJ was born with a rare disease, which could cause a potentially fatal amount of…
GGenetics Read More Opus Genetics’ BEST1 Gene Therapy IND Cleared by FDAAugust 18, 2025 Opus Genetics (Nasdaq: IRD) has received FDA clearance for its…
GGenetics Read More New generation of CRISPR shows safer path to treating genetic diseasesAugust 17, 2025 A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases…
EEntrepreneurship Read More Join Sept. 18 with George Church and this year’s top biotech startupsAugust 13, 2025 I asked AI the othÂer day how many biotechs have been co-foundÂed by HarÂvard’s George Church. About 50…
GGenetics Read More Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate UpdateAugust 13, 2025 Opus Genetics, Inc. – Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data…
BBusiness Read More Ousted FDA vaccine chief Vinay Prasad returning to agencyAugust 11, 2025 WASHINGTON (AP) — A Food and Drug Administration official is getting his job back as the agency’s top…
GGenetics Read More Genetic insights into the origin, admixture, and migration of the early Austronesian peoplesAugust 7, 2025 Shutler R, Marck JC. On the dispersal of the Austronesian horticulturalists. Archaeology Phys Anthropol Ocean. 1975;10:81–113. Google Scholar …
GGenetics Read More When ganglioside pathways go awry: congenital disorders and experimental insightsJuly 31, 2025 Thudichum JLW. A treatise on the chemical constitution of the brain: Bailliere, Tindall, and Cox, London; 1884. Chiricozzi…
BBusiness Read More FDA vaccine chief Vinay Prasad leaves following criticism from Laura LoomerJuly 30, 2025 WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief…
GGenetics Read More Rocket’s PKP2-Arrhythmogenic Cardiomyopathy Gene Therapy RP-A601 Snags RMAT DesignationJuly 29, 2025 Rocket Pharmaceuticals’ RP-A601, an investigational adeno-associated virus (AAV) vector-based gene therapy intended to treat plakophilin-2 related Arrhythmogenic Cardiomyopathy…
GGenetics Read More NGLY1 deficiency – clinical features and therapeutic strategyJuly 29, 2025 Suzuki T. Catabolism of N-glycoproteins in mammalian cells: molecular mechanisms and genetic disorders related to the processes. Mol…
BBusiness Read More As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middleJuly 25, 2025 Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…